Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

30-07-2024

The faces of Long-COVID: interplay of symptom burden with socioeconomic, behavioral and healthcare factors

Auteurs: Carolyn E. Schwartz, Katrina Borowiec, Bruce D. Rapkin

Gepubliceerd in: Quality of Life Research | Uitgave 10/2024

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Aims

The long-term effects of COVID-19 (Long COVID) include 19 symptoms ranging from mild to debilitating. We examined multidimensional correlates of Long COVID symptom burden.

Methods

This study focused on participants who reported having had COVID in Spring 2023 (n = 656; 85% female, mean age = 55, 59% college). Participants were categorized into symptom-burden groups using Latent Profile Analysis of 19 Long-COVID symptoms. Measures included demographics; quality of life and well-being (QOL); and COVID-specific stressors. Bivariate and multivariate associations of symptom burden were examined.

Results

A three-profile solution reflected low, medium, and high symptom burden, aligning with diagnosis confirmation and treatment by a healthcare provider. Higher symptom burden was associated with reporting more comorbidities; being unmarried, difficulty paying bills, being disabled from work, not having a college degree, younger age, higher body mass index, having had COVID multiple times, worse reported QOL, greater reported financial hardship and worry; maladaptive coping, and worse healthcare disruption, health/healthcare stress, racial-inequity stress, family-relationship problems, and social support. Multivariate modeling revealed that financial hardship, worry, risk-taking, comorbidities, health/healthcare stress, and younger age were risk factors for higher symptom burden, whereas social support and reducing substance use were protective factors.

Conclusions

Long-COVID symptom burden is associated with substantial, modifiable social and behavioral factors. Most notably, financial hardship was associated with more than three times the risk of high versus low Long-COVID symptom burden. These findings suggest the need for multi-pronged support in the absence of a cure, such as symptom palliation, telehealth, social services, and psychosocial support.
vorige artikel Long-term effects of the COVID-19 pandemic for patients with cancer
volgende artikel The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
2.
3.
4.
5.
6.
Nalbandian, A., Desai, A. D., & Wan, E. Y. (2023). Post-COVID-19 condition. Annual Review of Medicine, 74, 55–64.PubMedCrossRef
7.
8.
Fritsche, L. G., Jin, W., Admon, A. J., & Mukherjee, B. (2023). Characterizing and predicting post-acute sequelae of SARS CoV-2 infection (PASC) in a large academic medical center in the US. Journal of Clinical Medicine, 12(4), 1328.PubMedPubMedCentralCrossRef
9.
Voss, J. G., Pinto, M. D., & Burton, C. W. (2023). How do the social determinants of health impact the post-acute sequelae of COVID-19: A critical review. Nursing Clinics, 58(4), 541–568.PubMed
10.
11.
Knight, D. R., Munipalli, B., Logvinov, I. I., Halkar, M. G., Mitri, G., & Hines, S. L. (2022). Perception, prevalence, and prediction of severe infection and post-acute sequelae of COVID-19. The American Journal of the Medical Sciences, 363(4), 295–304.PubMedPubMedCentralCrossRef
12.
Kaushalya, L., Bowatte, G., Welikannage, K., & Yasaratne, D. (2022). Post-acute COVID-19 syndrome and predicting factors: A narrative review. Sri Lankan Journal of Health Sciences, 1(2), 36–47.CrossRef
13.
Azzam, A., & Khaled, H. (2023). Exploring the prevalence and factors associated with post-acute COVID syndrome in Egypt: A systematic review and meta-analysis. The Egyptian Journal of Internal Medicine, 35(1), 67.CrossRef
14.
Cavaco, S., Sousa, G., Gonçalves, A., et al. (2023). Predictors of cognitive dysfunction one-year post COVID-19. Neuropsychology, 37(5), 557–567.PubMedCrossRef
15.
Arjun, M., Singh, A. K., Pal, D., et al. (2022). Characteristics and predictors of long COVID among diagnosed cases of COVID-19. PLoS ONE, 17(12), e0278825.PubMedPubMedCentralCrossRef
16.
Munipalli, B., Ma, Y., Li, Z., et al. (2023). Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital. Journal of Investigative Medicine, 71(8), 896–906.PubMedCrossRef
17.
Schilling, C., Nieters, A., Schredl, M., et al. (2024). Pre-existing sleep problems as a predictor of post-acute sequelae of COVID-19. Journal of Sleep Research, 33(2), e13949.PubMedCrossRef
18.
Jacobs, E. T., Catalfamo, C. J., Colombo, P. M., et al. (2023). Pre-existing conditions associated with post-acute sequelae of COVID-19. Journal of Autoimmunity, 135, 102991.PubMedPubMedCentralCrossRef
19.
Greißel, A., Schneider, A., Donnachie, E., Gerlach, R., Tauscher, M., & Hapfelmeier, A. (2024). Impact of pre-existing mental health diagnoses on development of post-COVID and related symptoms: A claims data-based cohort study. Scientific Reports, 14(1), 2408.PubMedPubMedCentralCrossRef
20.
Yokoyama, T., & Gochuico, B. R. (2021). Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease. European Respiratory Review, 30(159), 200193.PubMedPubMedCentralCrossRef
21.
Poenaru, S., Abdallah, S. J., Corrales-Medina, V., & Cowan, J. (2021). COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Therapeutic Advances in Infectious Disease, 8, 20499361211009384.PubMedPubMedCentralCrossRef
22.
23.
Lapin, B., Li, Y., Englund, K., & Katzan, I. L. (2024). Health-related quality of life for patients with post-acute COVID-19 syndrome: Identification of symptom clusters and predictors of long-term outcomes. Journal of General Internal Medicine, 39, 1–9.CrossRef
24.
Hartung, T. J., Bahmer, T., Chaplinskaya-Sobol, I., et al. (2024). Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinical Medicine, 69, 102456.CrossRef
25.
Picascia, M., Cerami, C., Panzavolta, A., et al. (2023). Risk factors for post-COVID cognitive dysfunctions: The impact of psychosocial vulnerability. Neurological Sciences, 44(8), 2635–2642.PubMedCrossRef
26.
Gezici, A., & Ozay, O. (2020). How race and gender shape COVID-19 unemployment probability. University of Masssachusetts.CrossRef
27.
Moen, P., Pedtke, J. H., & Flood, S. (2020). Disparate disruptions: Intersectional COVID-19 employment effects by age, gender, education, and race/ethnicity. Work, Aging and Retirement, 6(4), 207–228.PubMedPubMedCentralCrossRef
28.
Navar, A. M., Purinton, S. N., Hou, Q., Taylor, R. J., & Peterson, E. D. (2021). The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19. PLoS ONE, 16(7), e0254809.PubMedPubMedCentralCrossRef
29.
Polyakova, M., Udalova, V., Kocks, G., Genadek, K., Finlay, K., & Finkelstein, A. N. (2021). Racial disparities in excess all-cause mortality during the early COVID-19 pandemic varied substantially across states: Study examines the geographic variation in excess all-cause mortality by race to better understand the impact of the COVID-19 pandemic. Health Affairs, 40(2), 307–316.PubMedCrossRef
30.
Lemogne, C., Gouraud, C., Pitron, V., & Ranque, B. (2023). Why the hypothesis of psychological mechanisms in long COVID is worth considering. Journal of Psychosomatic Research, 165, 111135.PubMedPubMedCentralCrossRef
31.
Tsai, J., Grace, A., Espinoza, R., & Kurian, A. (2023). Incidence of long COVID and associated psychosocial characteristics in a large US city. Social Psychiatry and Psychiatric Epidemiology, 37(5), 557–567.
32.
Hossain, M. M., Das, J., Rahman, F., et al. (2023). Living with “long COVID”: A systematic review and meta-synthesis of qualitative evidence. PLoS ONE, 18(2), e0281884.PubMedPubMedCentralCrossRef
33.
Bota, A. V., Bratosin, F., Bogdan, I., et al. (2024). Assessing the quality of life, coping strategies, anxiety and depression levels in patients with long-COVID-19 syndrome: A six-month follow-up study. Diseases, 12(1), 21.PubMedPubMedCentralCrossRef
34.
Pantelic, M., Ziauddeen, N., Boyes, M., O’Hara, M. E., Hastie, C., & Alwan, N. A. (2022). The prevalence of stigma in a UK community survey of people with lived experience of long COVID. The Lancet, 400, S84.CrossRef
35.
COVID-19 BSSR Research Tools (NIH Office of Behavioral and Social Sciences Research (OBSSR)). (2020).
36.
37.
NeuroQOL. (2021). Quality of life in neurological disorders scoring manual, version 3.0.
38.
39.
Ryff, C. D. (1989). Happiness is everything, or is it? Explorations on the meaning of psychological well-being. Journal of Personality and Social Psychology, 57, 1069–1081.CrossRef
40.
Schwartz, C. E., Borowiec, K., Waldman, A. H., et al. (2024). Emerging priorities and concerns in the wake of the COVID-19 pandemic: Qualitative and quantitative findings from a United States national survey. Frontiers in Public Health, 12, 1365657.PubMedPubMedCentralCrossRef
41.
Shevlin, M., & Miles, J. N. (1998). Effects of sample size, model specification and factor loadings on the GFI in confirmatory factor analysis. Personality and Individual Differences, 25(1), 85–90.CrossRef
42.
Collins, L. M., & Lanza, S. T. (2009). Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences (Vol. 718). Wiley.CrossRef
43.
Nylund-Gibson, K., & Choi, A. Y. (2018). Ten frequently asked questions about latent class analysis. Translational Issues in Psychological Science, 4(4), 440.CrossRef
44.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates.
45.
Hosmer, D. W., & Lemeshow, S. (1989). Model-building strategies and methods for logistic regression. In D. W. Hosmer, S. Lemeshow, & R. X. Sturdivant (Eds.), Applied logistic regression (pp. 82–134). Wiley.
46.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA, 273(1), 59–65.PubMedCrossRef
47.
IBM. (2021). SPSS Statistics for Windows. Version 28. IBM Corp.
48.
Muthén, L.K., & Muthén, B. O. (1998–2017). Mplus user's guide. Eighth ed. Cham: Muthén & Muthén.
49.
Krieger, N., Testa, C., Chen, J. T., Hanage, W. P., & McGregor, A. J. (2022). Relationship of political ideology of US federal and state elected officials and key COVID pandemic outcomes following vaccine rollout to adults: April 2021–March 2022. The Lancet Regional Health-Americas, 16, 100384.PubMedCrossRef
50.
Moore, S., & Kawachi, I. (2017). Twenty years of social capital and health research: A glossary. Journal of Epidemiology and Community Health, 71(5), 513–517.PubMedCrossRef
51.
Rose, M. S., Koshman, M. L., Spreng, S., & Sheldon, R. (1999). Statistical issues encountered in the comparison of health-related quality of life in diseased patients to published general population norms: Problems and solutions. Journal of Clinical Epidemiology., 52(5), 405–412.PubMedCrossRef
52.
Ladds, E., Rushforth, A., Wieringa, S., et al. (2020). Persistent symptoms after Covid-19: Qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Services Research, 20, 1–13.CrossRef
53.
54.
Gheorghita, R., Soldanescu, I., Lobiuc, A., et al. (2024). The knowns and unknowns of long COVID-19: From mechanisms to therapeutical approaches. Frontiers in Immunology, 15, 1344086.PubMedPubMedCentralCrossRef
55.
Rapkin, B. D., & Trickett, E. J. (2005). Comprehensive dynamic trial designs for behavioral prevention research with communities: Overcoming inadequacies of the randomized controlled trial paradigm. In E. J. Trickett & W. Pequegnat (Eds.), Community interventions and AIDS (pp. 249–277). Oxford University Press.CrossRef
56.
Karmakar, M., Lantz, P. M., & Tipirneni, R. (2021). Association of social and demographic factors with COVID-19 incidence and death rates in the US. JAMA Network Open, 4(1), e2036462–e2036462.PubMedPubMedCentralCrossRef
57.
Rossen, L. M., Nørgaard, S. K., Sutton, P. D., et al. (2022). Excess all-cause mortality in the USA and Europe during the COVID-19 pandemic, 2020 and 2021. Scientific Reports, 12(1), 18559.PubMedPubMedCentralCrossRef
58.
Hacker, K. A., Briss, P. A., Richardson, L., Wright, J., & Petersen, R. (2021). COVID-19 and chronic disease: The impact now and in the future. Preventing Chronic Disease, 18, 1–6.CrossRef
59.
Islam, N., Lacey, B., Shabnam, S., et al. (2021). Social inequality and the syndemic of chronic disease and COVID-19: County-level analysis in the USA. Journal of Epidemiology and Community Health, 75(6), 496–500.CrossRef
60.
Nunnally, J. C. (1994). Psychometric theory (3rd ed.). Tata McGraw-Hill Education.
Metagegevens
Titel
The faces of Long-COVID: interplay of symptom burden with socioeconomic, behavioral and healthcare factors
Auteurs
Carolyn E. Schwartz
Katrina Borowiec
Bruce D. Rapkin
Publicatiedatum
30-07-2024
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2024
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-024-03739-4

Andere artikelen Uitgave 10/2024

Global quality of life and mortality risk in patients with cancer: a systematic review and meta-analysis

  • Review

Measuring what matters to older persons for active living: part I content development for the OPAL measure across four countries

Health-related quality of life in ethnically diverse Black prostate cancer survivors: a convergent parallel mixed-methods approach

The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments

  • Open Access

Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making

  • Open Access

Health-related quality of life and radioiodine therapy in thyroid cancer patients: a before-and-after study